In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 142 for your search:
Drug:  methylprednisolone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Under 46
Sponsor: Other
Protocol IDs: UMN-MT-1995-06, UMN-9224, UMN-MT-9506, NCI-V00-1605, NCT00006451
2.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 12 to 50
Sponsor: Other
Protocol IDs: CHIMERIC-HM01, WSU-10-02-99-M01-FB, NCT00004255
3.

Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069401, U10CA037420, URCC-U1902, URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742
4.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 55 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000066016, P30CA016059, MCV-CCHR-9504-2X, DUMC-75951, NCI-G98-1388, NCT00003187
5.

Phase: Phase III, Phase I
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: DFCI-76006, DFCI-VAPA-10
6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, T94-0040, NCT00002565
7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: MRC-LEUK-MYEL-VII, EU-94030, NCT00002599
8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21 at diagnosis
Sponsor: NCI
Protocol IDs: CCG-5942
9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: E-2493, E2493
10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI, Other
Protocol IDs: MDA DM95-121, P30CA016672, NCI-V96-1010, CDR0000065044, NCT00002835
11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: SAKK 38/97, SWS-SAKK-38/97, EU-97037, NCT00003215
12.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: CDR0000066202, DFCI-95001, DFCI-FDR001197, NCI-G99-1651, NCT00004034
13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and under
Sponsor: Other
Protocol IDs: CDR0000066742, FNCLCC-SFOP-96006-LMT-96, EU-98049, NCT00003650
14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000066784, FRE-FNCLCC-GETUG-02, EU-98058, NCT00003682
15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CDR0000066840, EORTC-58951, NCT00003728
16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: BTSG-7501
17.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-82-C-111
18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: SEG-78ALL333
19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: SAFR-CT-MM-1
20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 2 to 55
Sponsor:
Protocol IDs: OSU-83HO268, NCI-V84-0067
21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: CCG-945
22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 2 to 55
Sponsor:
Protocol IDs: OSU-83HO270, NCI-V84-0070
23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 14 to 55
Sponsor:
Protocol IDs: OSU-84HO226, NCI-V85-0224
24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 55 and under
Sponsor:
Protocol IDs: FHCRC-431, NCI-V89-0262
25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: CCG-921
1     
New Search